Panacea Life Sciences Holdings, Inc. (PLSH) Shareholders’ equity 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) shareholders’ equity at each fiscal year-end, per SEC filings.
-$8.3MFY2023 · since FY2014: $45,764 → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$8.3M | -286.6% |
| FY2022 | -$2.1M | -130.2% |
| FY2021 | $7.1M | +5.9% |
| FY2020 | $6.7M | -43.8% |
| FY2019 | $11.9M | +448.7% |
| FY2018 | -$3.4M | -54.6% |
| FY2017 | -$2.2M | -247.7% |
| FY2016 | $1.5M | +1707.5% |
| FY2015 | -$93,320 | -303.9% |
| FY2014 | $45,764 | — |
Source: SEC XBRL filings · For reference only · Not investment advice